VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s stock price reached a new 52-week low during trading on Tuesday . The stock traded as low as C$0.09 and last traded at C$0.09, with a volume of 197364 shares traded. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Trading Up 5.9 %
The company has a current ratio of 0.28, a quick ratio of 6.67 and a debt-to-equity ratio of -58.56. The business has a 50 day simple moving average of C$0.10 and a two-hundred day simple moving average of C$0.14. The stock has a market cap of C$14.60 million, a price-to-earnings ratio of -2.78 and a beta of 0.39.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Read More
- Five stocks we like better than VentriPoint Diagnostics
- Upcoming IPO Stock Lockup Period, Explained
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Technology Stocks Explained: Here’s What to Know About Tech
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
